Rashedi Alexandra S, de Roo Saskia F, Ataman Lauren M, Edmonds Maxwell E, Silva Adelino Amaral, Scarella Anibal, Horbaczewska Anna, Anazodo Antoinette, Arvas Ayse, Ramalho de Carvalho Bruno, Sartorio Cassio, Beerendonk Catharina C M, Diaz-Garcia Cesar, Suh Chang Suk, Melo Cláudia, Andersen Claus Yding, Motta Eduardo, Greenblatt Ellen M, Van Moer Ellen, Zand Elnaz, Reis Fernando M, Sánchez Flor, Terrado Guillermo, Rodrigues Jhenifer K, Marcos de Meneses E Silva Joao, Smitz Johan, Medrano Jose, Lee Jung Ryeol, Winkler-Crepaz Katharina, Smith Kristin, Ferreira Melo E Silva Lígia Helena, Wildt Ludwig, Salama Mahmoud, Del Mar Andrés María, Bourlon Maria T, Vega Mario, Chehin Maurício Barbour, De Vos Michel, Khrouf Mohamed, Suzuki Nao, Azmy Osama, Fontoura Paula, Campos-Junior Paulo Henrique Almeida, Mallmann Peter, Azambuja Ricardo, Marinho Ricardo M, Anderson Richard A, Jach Robert, Antunes Roberto de A, Mitchell Rod, Fathi Rouhollah, Adiga Satish Kumar, Takae Seido, Kim Seok Hyun, Romero Sergio, Grieco Silvana Chedid, Shaulov Talya, Furui Tatsuro, Almeida-Santos Teresa, Nelen Willianne, Jayasinghe Yasmin, Sugishita Yodo, Woodruff Teresa K
Northwestern University, Chicago, IL.
Radboud University Medical Center, Nijmegen, the Netherlands.
JCO Glob Oncol. 2020 Mar 2;6. doi: 10.1200/JGO.2017.009944. eCollection 2020.
In the accompanying article, "Survey of Fertility Preservation Options Available to Patients With Cancer Around the Globe," we showed that specific fertility preservation services may not be offered at various sites around the world because of cultural and legal barriers. We assessed global and regional experiences as well as the legal status of third-party reproduction and adoption to serve as a comprehensive international data set and resource for groups that wish to begin oncofertility interventions.
We provide data on the legalities of third-party assisted reproductive technologies and other family-building options in the 28 oncofertility-practicing countries surveyed.
We found regional and country differences that will be important in the development of tailored resources for physicians and for patient brochures that are sensitive to these local restrictions and cultural norms.
Because many patients first consult Web-based materials, the formal assessment of the availability of these options provides members of the global oncofertility community with data to which they might otherwise not have ready access to better serve their patients.
在随附文章《全球癌症患者可选择的生育力保存调查》中,我们表明,由于文化和法律障碍,世界各地的不同机构可能无法提供特定的生育力保存服务。我们评估了全球和地区的经验以及第三方生殖和收养的法律状况,以作为希望开展肿瘤生育力干预措施的团体的全面国际数据集和资源。
我们提供了在接受调查的28个开展肿瘤生育力治疗的国家中,第三方辅助生殖技术及其他组建家庭方式的合法性数据。
我们发现了地区和国家差异,这对于为医生开发量身定制的资源以及编写对这些当地限制和文化规范敏感的患者手册非常重要。
由于许多患者首先会查阅网络资料,对这些选择的可用性进行正式评估为全球肿瘤生育力界的成员提供了数据,否则他们可能无法轻易获取这些数据,从而更好地为患者服务。